drug protocol number

MO22223

drug sponsor

Roche

drug study

Bevacizumab+ Capecitabine

drug trial site

King Abdulaziz Hospital and Oncology Center (Jeddah), King Abdulaziz Medical City NG (Riyadh), King Fahad Specialist Hospital (Dammam)

drug status

Terminated

drug phase